These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 21031436

  • 1. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X, Choi RY, Jawad SM, Arnold JT.
    Prostate; 2011 May 15; 71(7):766-77. PubMed ID: 21031436
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.
    Lee SO, Lou W, Hou M, Onate SA, Gao AC.
    Oncogene; 2003 Sep 11; 22(39):7981-8. PubMed ID: 12970746
    [Abstract] [Full Text] [Related]

  • 3. PSA regulates androgen receptor expression in prostate cancer cells.
    Saxena P, Trerotola M, Wang T, Li J, Sayeed A, Vanoudenhove J, Adams DS, Fitzgerald TJ, Altieri DC, Languino LR.
    Prostate; 2012 May 15; 72(7):769-76. PubMed ID: 21956655
    [Abstract] [Full Text] [Related]

  • 4. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M, Sun Z.
    Mol Endocrinol; 2005 Feb 15; 19(2):391-8. PubMed ID: 15514031
    [Abstract] [Full Text] [Related]

  • 5. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
    Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B.
    Prostate; 2011 Sep 15; 71(12):1276-86. PubMed ID: 21308712
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 7. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
    Shankar E, Song K, Corum SL, Bane KL, Wang H, Kao HY, Danielpour D.
    J Biol Chem; 2016 Mar 11; 291(11):5512-5526. PubMed ID: 26786102
    [Abstract] [Full Text] [Related]

  • 8. Androgen activates β-catenin signaling in bladder cancer cells.
    Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H.
    Endocr Relat Cancer; 2013 Jun 11; 20(3):293-304. PubMed ID: 23447569
    [Abstract] [Full Text] [Related]

  • 9. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
    Deep G, Oberlies NH, Kroll DJ, Agarwal R.
    Oncogene; 2008 Jun 26; 27(28):3986-98. PubMed ID: 18332867
    [Abstract] [Full Text] [Related]

  • 10. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH, Chang YL, Feng TH, Hou CP, Lin YH, Yang PS, Lee BW, Juang HH.
    Prostate; 2018 Mar 26; 78(4):242-249. PubMed ID: 29164633
    [Abstract] [Full Text] [Related]

  • 11. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
    Heer R, Robson CN, Shenton BK, Leung HY.
    J Cell Physiol; 2007 Sep 26; 212(3):572-8. PubMed ID: 17541959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
    Chesire DR, Ewing CM, Gage WR, Isaacs WB.
    Oncogene; 2002 Apr 18; 21(17):2679-94. PubMed ID: 11965541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J, McCubrey JA, Laidler P.
    Curr Med Chem; 2013 Apr 18; 20(1):144-57. PubMed ID: 23033951
    [Abstract] [Full Text] [Related]

  • 16. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J.
    Prostate; 2007 Feb 01; 67(2):178-89. PubMed ID: 17044040
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL, Hadjimichael C, Temperley R, Barnard A, Fuller-Pace FV, Robson CN.
    PLoS One; 2013 Feb 01; 8(1):e54150. PubMed ID: 23349811
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
    Yanase T, Fan W.
    Vitam Horm; 2009 Feb 01; 80():649-66. PubMed ID: 19251054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.